US Pharma MarketingMerck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances
More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions attributed to its $3 billion cost-cutting plan announced last July.
A Merck spokesperson attributed the layoffs to "the next phase of personnel impacts related to its multiyear optimization," which was unveiled last July.
Source: FiercePharma